Case report: Hemophagocytic lymphohistiocytosis in a child with primary immunodeficiency infected with Talaromyces marneffei
暂无分享,去创建一个
Yunjun Mo | Shilin Liu | Lintao Zhou | Hui-Min Yan | Xiuming Zhang | Lianlian Liu | Yunsheng Chen | Xiaojuan Luo | K. Cao
[1] Xiaodong Zhao,et al. Clinical, genetic and immunological characteristics of 40 Chinese patients with CD40 ligand deficiency , 2019, Scandinavian journal of immunology.
[2] Y. Lau,et al. Application of Flow Cytometry in the Diagnostics Pipeline of Primary Immunodeficiencies Underlying Disseminated Talaromyces marneffei Infection in HIV-Negative Children , 2019, Front. Immunol..
[3] Cunwei Cao,et al. Characteristics and Prognosis of Talaromyces marneffei Infection in Non-HIV-Infected Children in Southern China , 2019, Mycopathologia.
[4] K. Risma,et al. Hemophagocytic Lymphohistiocytosis: Clinical Presentations and Diagnosis. , 2019, The journal of allergy and clinical immunology. In practice.
[5] Y. Ruan,et al. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[6] H. Cao,et al. Recurrent fungal infections in a Chinese patient with CARD9 deficiency and a review of 48 cases , 2018, The British journal of dermatology.
[7] A. Aghamohammadi,et al. The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management. , 2019, Clinical immunology.
[8] M. Lionakis,et al. Human CARD9: A Critical Molecule of Fungal Immune Surveillance , 2018, Front. Immunol..
[9] Z. Wan,et al. Impaired Specific Antifungal Immunity in CARD9-Deficient Patients with Phaeohyphomycosis. , 2017, The Journal of investigative dermatology.
[10] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[11] Y. Lau,et al. Cellular and Molecular Defects Underlying Invasive Fungal Infections—Revelations from Endemic Mycoses , 2017, Front. Immunol..
[12] J. Farrar,et al. A Trial of Itraconazole or Amphotericin B for HIV‐Associated Talaromycosis , 2017, The New England journal of medicine.
[13] Zhongyuan Lin,et al. Retrospective analysis of 15 cases of Penicillium marneffei infection in HIV-positive and HIV-negative patients. , 2017, Microbial pathogenesis.
[14] E. Diao. Clinical Presentations and Diagnosis , 2017 .
[15] M. T. de la Morena,et al. Clinical Phenotypes of Hyper-IgM Syndromes. , 2016 .
[16] J. Nosanchuk,et al. Talaromyces marneffei laccase modifies THP-1 macrophage responses , 2016, Virulence.
[17] É. Azoulay,et al. Diversity and combinations of infectious agents in 38 adults with an infection-triggered reactive haemophagocytic syndrome: a multicenter study. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[18] P. Woo,et al. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients , 2016, Emerging Microbes & Infections.
[19] T. Morio,et al. Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan. , 2015, The Journal of allergy and clinical immunology.
[20] S. Spector,et al. Practice parameter for the diagnosis and management of primary immunodeficiency. , 2015, The Journal of allergy and clinical immunology.
[21] L. Santos‐Argumedo,et al. A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child , 2015, Immunologic Research.
[22] R. Geha,et al. A novel disease-causing CD40L mutation reduces expression of CD40 ligand, but preserves CD40 binding capacity. , 2014, Clinical immunology.
[23] Xiaodong Zhao,et al. Clinical, molecular, and T cell subset analyses in a small cohort of Chinese patients with hyper-IgM syndrome type 1. , 2014, Human immunology.
[24] Xiaolin Wang,et al. CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies. , 2014, The Journal of allergy and clinical immunology.
[25] Y. Lau,et al. Penicillium marneffei infection and impaired IFN-γ immunity in humans with autosomal-dominant gain-of-phosphorylation STAT1 mutations. , 2014, The Journal of allergy and clinical immunology.
[26] J. Verbsky,et al. Laboratory Diagnosis of Primary Immunodeficiencies , 2014, Clinical Reviews in Allergy & Immunology.
[27] M. Jordan,et al. Hemophagocytic lymphohistiocytosis: updates and evolving concepts , 2012, Current opinion in pediatrics.
[28] S. Davies,et al. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. , 2010, Blood.
[29] C. Khamwan,et al. Development of TaqMan real‐time polymerase chain reaction for the detection and identification of Penicillium marneffei , 2009, Mycoses.
[30] P. Easterbrook,et al. Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand gene , 2008, Journal of Clinical Pathology.
[31] M. Aricò,et al. HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.
[32] H. Ochs,et al. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. , 2005, Blood.
[33] J. Bertin,et al. CARD9 Is a Novel Caspase Recruitment Domain-containing Protein That Interacts With BCL10/CLAP and Activates NF-κB* , 2000, The Journal of Biological Chemistry.
[34] C. Kinnon,et al. Mutation analysis in CD40 ligand deficiency leading to X‐linked hypogammaglobulinemia with hyper IgM syndrome , 1996, Human mutation.